Penile rehabilitation in patients following surgical treatment of Peyronie’s disease
https://doi.org/10.21886/2308-6424-2023-11-2-144-153
Abstract
Peyronie's disease (PD) is an acquired disease, which is based on a violation of the wound healing process, which results in the formation of fibrous plaques in the tunica albuginea of the cavernous bodies. The prevalence of erectile dysfunction (ED) among patients with PD ranges from 22% to 54%, according to various studies. Surgical treatment remains the "gold standard" for correcting penile curvature in PD. It is important to note that the existing methods of PD surgery (techniques with shortening or lengthening of the tunica albuginea) carry the risks of developing ED or aggravating its severity. At the same time, the absence of adequate sexual rehabilitation following PD surgery is associated with a significant deterioration in functional outcomes. In view of the above, the article is aimed to systematise information on penile rehabilitation methods in patients following PD surgery, which showed that the problem remains relevant to the present day. Most existing penile rehabilitation methods are currently not sufficiently investigated, and it is therefore impossible to give clear recommendations on the use of any method. The small number of well-designed and randomised studies on this problem is noteworthy, most likely due to the relative rarity of the disease.
Supporting agencies: The study was not sponsored
About the Authors
S. V. Kotov
Pirogov Russian National Research Medical University (Pirogov Medical University); «Kommunarka» Moscow Multidisciplinary Clinical Centre; Pirogov City Clinical Hospital No.1
Russian Federation
Competing Interests:
Russian Federation
Sergey V. Kotov — M.D., Dr.Sc. (Med), Full Prof.; Head, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Head, University Clinic of Urology, Oncourology and Andrology, «Kommunarka» Moscow Multidisciplinary Clinical Centre; Urologist, Urology Division, Pirogov City Clinical Hospital No.1.
Moscow
Competing Interests:
The authors declare no conflicts of interest
A. G. Yusufov
Pirogov Russian National Research Medical University (Pirogov Medical University); «Kommunarka» Moscow Multidisciplinary Clinical Centre
Russian Federation
Competing Interests:
Russian Federation
Anvar G. Yusufov — M.D., Cand.Sc.(Med); Assoc.Prof., Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Head, Urology Division, «Kommunarka» Moscow Multidisciplinary Clinical Centre.
Moscow
Competing Interests:
The authors declare no conflicts of interest
N. M. Sokolov
Pirogov Russian National Research Medical University (Pirogov Medical University)
Russian Federation
Competing Interests:
Russian Federation
Nikita M. Sokolov — M.D.; Postgrad. Student, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University).
Moscow
Competing Interests:
The authors declare no conflicts of interest
R. U. Mammaev
Pirogov Russian National Research Medical University (Pirogov Medical University)
Russian Federation
Competing Interests:
Russian Federation
Ramazan U. Mammaev — Resident, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University).
Moscow
Competing Interests:
The authors declare no conflicts of interest
References
1. Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516. DOI: 10.1111/iju.14230
2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001;88(7):727-30. DOI: 10.1046/j.1464-4096.2001.02436.x
3. Kadioglu A, Sanli O, Akman T, Canguven O, Aydin M, Akbulut F, Kucukdurmaz F. Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients. J Androl. 2011;32(5):502-8. DOI: 10.2164/jandrol.110.011031
4. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie's disease. J Urol. 2002;168(3):1075-9. DOI: 10.1016/S0022-5347(05)64578-8
5. Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease. J Sex Med. 2008;5(9):2179-84. DOI: 10.1111/j.1743-6109.2008.00949.x
6. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. J Sex Med. 2008;5(8):1985-90. DOI: 10.1111/j.1743-6109.2008.00895.x
7. Chung E, Ralph D, Kagioglu A, Garaffa G, Shamsodini A, Bivalacqua T, Glina S, Hakim L, Sadeghi-Nejad H, Broderick G. Evidence-Based Management Guidelines on Peyronie's Disease. J Sex Med. 2016;13(6):905-23. DOI: 10.1016/j.jsxm.2016.04.062
8. Montague DK. Peyronie disease and erectile dysfunction: A potential new paradigm. Cleve Clin J Med. 2021;88(12):661-663. DOI: 10.3949/ccjm.88a.21027
9. Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017;6(1):46-59. DOI: 10.21037/tau.2016.11.01
10. Sansalone S, Garaffa G, Djinovic R, Pecoraro S, Silvani M, Barbagli G, Zucchi A, Vespasiani G, Loreto C. Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. Asian J Androl. 2011;13(6):842-5. DOI: 10.1038/aja.2011.42
11. Hakky TS, Baumgarten AS, Parker J, Zheng Y, Kongnyuy M, Martinez D, Carrion RE. Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction. Curr Urol Rep. 2014;15(4):393. DOI: 10.1007/s11934-014-0393-6
12. Kuthe A. Phosphodiesterase 5 inhibitors in male sexual dysfunction. Curr Opin Urol. 2003;13:405-410. DOI: 10.1097/01.mou.0000088747.16181.4b
13. Alwaal A, Al-Mannie R, Carrier S. Future prospects in the treatment of erectile dysfunction: focus on avanafil. Drug Des Devel Ther. 2011;5:435-43. DOI: 10.2147/DDDT.S15852
14. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9(4):229-44. DOI: 10.1016/j.niox.2003.12.002
15. Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide. 2002;7(4):262-76. DOI: 10.1016/s1089-8603(02)00124-6
16. Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008;20(2):202-12. DOI: 10.1038/sj.ijir.3901612
17. Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int. 2006;97(3):625-33. DOI: 10.1111/j.1464-410X.2006.05955.x
18. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008;101(2):203-10. DOI: 10.1111/j.1464-410X.2007.07223.x
19. Levine LA, Greenfield JM, Estrada CR. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med. 2005;2(2):241-7. DOI: 10.1111/j.1743-6109.2005.20234.x
20. Chung E, Deyoung L, Brock GB. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011;8(5):1472-7. DOI: 10.1111/j.1743-6109.2011.02217.x
21. Smith WB 2nd, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67(8):768-80. DOI: 10.1111/ijcp.12074
22. Levine LA. Peyronie's disease and erectile dysfunction: Current understanding and future direction. Indian Journal of Urology. 2006;22:246.
23. Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction--science and clinical evidence. Int J Impot Res. 2010;22(4):211-9. Erratum in: Int J Impot Res. 2010;22(4):290. PMID: 20410903. DOI: 10.1038/ijir.2010.4.
24. Yang XL, Yang Y, Fu FD, Wu CJ, Qin F, Yuan JH. Optimal pressure in penile rehabilitation with a vacuum erection device: evidence based on a rat model. Asian J Androl. 2019;21(5):516-521. DOI: 10.4103/aja.aja_7_19
25. Lin HC, Yang WL, Zhang JL, Dai YT, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl. 2013;15(3):387-90. DOI: 10.1038/aja.2013.18
26. Lin H, Wang G, Wang R,. Vacuum erectile device for penile rehabilitation. Journal of Integrative Nephrology and Andrology. 2014;1(1):4-10. DOI: 10.4103/2225-1243.137541
27. Avant RA, Ziegelmann M, Nehra A, Alom M, Kohler T, Trost L. Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease. Sex Med Rev. 2019;7(2):338-348. DOI: 10.1016/j.sxmr.2018.02.005
28. Osadchinskii A.E., Pavlov I.S., Kotov S.V. Penile rehabilitation in patients after radical prostatectomy. Experimental and Clinical Urology. 2021;14(3):73-79. DOI: 10.29188/2222-8543-2021-14-3-73-79
29. Lue TF, El-Sakka AI. Lengthening shortened penis caused by Peyronie's disease using circular venous grafting and daily stretching with a vacuum erection device. J Urol. 1999;161(4):1141-4. PMID: 10081856.
30. Yurkanin JP, Dean R, Wessells H. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction. J Urol. 2001;166(5):1769-72; discussion 1772-3. PMID: 11586221.
31. Valenzuela R, Ziegelmann M, Tokar S, Hillelsohn J. The use of penile traction therapy in the management of Peyronie's disease: current evidence and future prospects. Ther Adv Urol. 2019;11:1756287219838139. DOI: 10.1177/1756287219838139
32. Mehr J, Santarelli S, Green TP, Beetz J, Panuganti S, Wang R. Emerging Roles of Penile Traction Therapy and Vacuum Erectile Devices. Sex Med Rev. 2022;10(3):421-433. DOI: 10.1016/j.sxmr.2021.12.003
33. Chung E, De Young L, Solomon M, Brock GB. Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system. J Sex Med. 2013;10(5):1259-67. DOI: 10.1111/jsm.12082
34. Usta MF, Ipekci T. Penile traction therapy for Peyronie's disease-what's the evidence? Transl Androl Urol. 2016;5(3):303-9. DOI: 10.21037/tau.2016.03.25
35. Lin H, Liu C, Wang R. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model. J Sex Med. 2017;14(10):1270-1276. DOI: 10.1016/j.jsxm.2017.08.011
36. Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Köhler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021;206(2):416-426. DOI: 10.1097/JU.0000000000001792
37. Moncada-Iribarren I, Jara J, Martinez-Salamanca JI, Cabello R, Hernandez C. Managing Penile Shortening after Peyronie’s Disease Surgery. Journal of Urology. 2007;177(4S):252-252. DOI:10.1016/s0022-5347(18)30990-x
38. Rybak J, Papagiannopoulos D, Levine L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions. J Sex Med. 2012;9(9):2396-403. DOI: 10.1111/j.1743-6109.2012.02849.x
39. Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019;202(3):599-610. DOI: 10.1097/JU.0000000000000245
40. Porst H. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients. Sex Med Rev. 2021;9(1):93-122. DOI: 10.1016/j.sxmr.2020.01.006
41. Jiang P, Christakos A, Fam M, Sadeghi-Nejad H. Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients. Korean J Urol. 2014;55(10):665-9. DOI: 10.4111/kju.2014.55.10.665
42. Baird B, Wajswol E, Ericson C, Anderson A, Broderick G. Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection. J Sex Med. 2022;19(4):590-593. DOI: 10.1016/j.jsxm.2022.01.520
43. Elgendi K, Zulia N, Beilan J. A Review on Penile Doppler and Ultrasonography for Erectile Dysfunction. Curr Urol Rep. 2023;24(2):69-74. DOI: 10.1007/s11934-022-01135-4
44. Israeli JM, Lokeshwar SD, Efimenko IV, Masterson TA, Ramasamy R. The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation. Int J Impot Res. 2022;34(4):375-382. DOI: 10.1038/s41443-021-00482-z
45. Alkandari MH, Touma N, Carrier S. Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence. Sex Med Rev. 2022;10(2):341-352. DOI: 10.1016/j.sxmr.2020.12.004
46. Sokolakis I, Pyrgidis N, Ziegelmann MJ, Mykoniatis I, Köhler TS, Hatzichristodoulou G. Penile Prosthesis Implantation Combined With Grafting Techniques in Patients With Peyronie's Disease and Erectile Dysfunction: A Systematic Review. Sex Med Rev. 2022;10(3):451-459. DOI: 10.1016/j.sxmr.2021.03.007
47. Levine LA, Becher EF, Bella AJ, Brant WO, Kohler TS, Martinez-Salamanca JI, Trost L, Morey AF. Penile Prosthesis Surgery: Current Recommendations From th e International Consultation on Sexual Medicine. J Sex Med. 2016;13(4):489-518. Erratum in: J Sex Med. 2016;13(7):1145. PMID: 27045255. DOI: 10.1016/j.jsxm.2016.01.017
Review
For citations:
Kotov S.V., Yusufov A.G., Sokolov N.M., Mammaev R.U. Penile rehabilitation in patients following surgical treatment of Peyronie’s disease. Urology Herald. 2023;11(2):144-153. (In Russ.) https://doi.org/10.21886/2308-6424-2023-11-2-144-153
Views:
2812
Email this article 
